IBDEI0WI ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16091,0)
 ;;=99244^^102^995^4
 ;;^UTILITY(U,$J,358.3,16091,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16091,1,1,0)
 ;;=1^Comprehensive, Moderate
 ;;^UTILITY(U,$J,358.3,16091,1,2,0)
 ;;=2^99244
 ;;^UTILITY(U,$J,358.3,16092,0)
 ;;=99245^^102^995^5
 ;;^UTILITY(U,$J,358.3,16092,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16092,1,1,0)
 ;;=1^Comprehensive, High
 ;;^UTILITY(U,$J,358.3,16092,1,2,0)
 ;;=2^99245
 ;;^UTILITY(U,$J,358.3,16093,0)
 ;;=99024^^102^996^1
 ;;^UTILITY(U,$J,358.3,16093,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16093,1,1,0)
 ;;=1^Post-Op Follow-up Visit
 ;;^UTILITY(U,$J,358.3,16093,1,2,0)
 ;;=2^99024
 ;;^UTILITY(U,$J,358.3,16094,0)
 ;;=99211^^103^997^1
 ;;^UTILITY(U,$J,358.3,16094,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16094,1,1,0)
 ;;=1^NURSING VISIT
 ;;^UTILITY(U,$J,358.3,16094,1,2,0)
 ;;=2^99211
 ;;^UTILITY(U,$J,358.3,16095,0)
 ;;=J3420^^104^998^5^^^^1
 ;;^UTILITY(U,$J,358.3,16095,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16095,1,2,0)
 ;;=2^J3420
 ;;^UTILITY(U,$J,358.3,16095,1,3,0)
 ;;=3^B12 INJ. UP TO 1,000MCG
 ;;^UTILITY(U,$J,358.3,16096,0)
 ;;=J3120^^104^998^54^^^^1
 ;;^UTILITY(U,$J,358.3,16096,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16096,1,2,0)
 ;;=2^J3120
 ;;^UTILITY(U,$J,358.3,16096,1,3,0)
 ;;=3^TESTOSTERONE ENANTHATE 100MG
 ;;^UTILITY(U,$J,358.3,16097,0)
 ;;=J1070^^104^998^52^^^^1
 ;;^UTILITY(U,$J,358.3,16097,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16097,1,2,0)
 ;;=2^J1070
 ;;^UTILITY(U,$J,358.3,16097,1,3,0)
 ;;=3^TESTOSTERONE CYPIONAT 100 MG
 ;;^UTILITY(U,$J,358.3,16098,0)
 ;;=J0800^^104^998^8^^^^1
 ;;^UTILITY(U,$J,358.3,16098,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16098,1,2,0)
 ;;=2^J0800
 ;;^UTILITY(U,$J,358.3,16098,1,3,0)
 ;;=3^CORTISON INJ, UP TO 40U
 ;;^UTILITY(U,$J,358.3,16099,0)
 ;;=J1080^^104^998^53^^^^1
 ;;^UTILITY(U,$J,358.3,16099,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16099,1,2,0)
 ;;=2^J1080
 ;;^UTILITY(U,$J,358.3,16099,1,3,0)
 ;;=3^TESTOSTERONE CYPIONAT 200 MG
 ;;^UTILITY(U,$J,358.3,16100,0)
 ;;=J3130^^104^998^55^^^^1
 ;;^UTILITY(U,$J,358.3,16100,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16100,1,2,0)
 ;;=2^J3130
 ;;^UTILITY(U,$J,358.3,16100,1,3,0)
 ;;=3^TESTOSTERONE ENANTHATE 200MG
 ;;^UTILITY(U,$J,358.3,16101,0)
 ;;=J1631^^104^998^20^^^^1
 ;;^UTILITY(U,$J,358.3,16101,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16101,1,2,0)
 ;;=2^J1631
 ;;^UTILITY(U,$J,358.3,16101,1,3,0)
 ;;=3^HALDOL 50MG
 ;;^UTILITY(U,$J,358.3,16102,0)
 ;;=J2680^^104^998^47^^^^1
 ;;^UTILITY(U,$J,358.3,16102,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16102,1,2,0)
 ;;=2^J2680
 ;;^UTILITY(U,$J,358.3,16102,1,3,0)
 ;;=3^PROLIXIN INJ UP TO 25MG
 ;;^UTILITY(U,$J,358.3,16103,0)
 ;;=J1630^^104^998^21^^^^1
 ;;^UTILITY(U,$J,358.3,16103,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16103,1,2,0)
 ;;=2^J1630
 ;;^UTILITY(U,$J,358.3,16103,1,3,0)
 ;;=3^HALDOL PER 5MG
 ;;^UTILITY(U,$J,358.3,16104,0)
 ;;=J9202^^104^998^57^^^^1
 ;;^UTILITY(U,$J,358.3,16104,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16104,1,2,0)
 ;;=2^J9202
 ;;^UTILITY(U,$J,358.3,16104,1,3,0)
 ;;=3^ZOLADEX 3.6MG
 ;;^UTILITY(U,$J,358.3,16105,0)
 ;;=J0885^^104^998^12^^^^1
 ;;^UTILITY(U,$J,358.3,16105,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16105,1,2,0)
 ;;=2^J0885
 ;;^UTILITY(U,$J,358.3,16105,1,3,0)
 ;;=3^EPOGEN INJ, NON-ESRD 1000 UNITS
 ;;^UTILITY(U,$J,358.3,16106,0)
 ;;=J0881^^104^998^4^^^^1
 ;;^UTILITY(U,$J,358.3,16106,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16106,1,2,0)
 ;;=2^J0881
 ;;^UTILITY(U,$J,358.3,16106,1,3,0)
 ;;=3^ARANESP (NON-ESRD) 1MCG
 ;;^UTILITY(U,$J,358.3,16107,0)
 ;;=J0882^^104^998^3^^^^1
